| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
61,550,000 |
| Market
Cap: |
470.24(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.15 - $10.77 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
47,230 |
49,902 |
154,336 |
184,160 |
| Total Sell Value |
$468,862 |
$489,917 |
$1,241,160 |
$1,516,545 |
| Total People Sold |
5 |
5 |
5 |
5 |
| Total Sell Transactions |
21 |
27 |
43 |
83 |
| End Date |
2025-10-09 |
2025-07-08 |
2025-01-07 |
2024-01-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Calkins Daniel |
Chief Financial Officer |
• – – |
2025-12-24 |
4 |
S |
$7.86 |
$629 |
D/D |
(80) |
109,758 |
|
13% |
|
| Gagnon Robert E. |
Director |
– • – |
2025-12-16 |
4 |
S |
$9.14 |
$2,587 |
D/D |
(283) |
41,678 |
|
20% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-16 |
4 |
S |
$9.14 |
$3,592 |
D/D |
(393) |
410,425 |
|
20% |
|
| Stuglik Brian M |
Director |
– • – |
2025-12-16 |
4 |
S |
$9.14 |
$5,411 |
D/D |
(592) |
101,147 |
|
20% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-11 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
410,818 |
|
-23% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-10 |
4 |
AS |
$10.07 |
$20,140 |
D/D |
(2,000) |
412,818 |
|
-28% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-09 |
4 |
AS |
$10.25 |
$20,500 |
D/D |
(2,000) |
414,818 |
|
-29% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-08 |
4 |
AS |
$10.50 |
$21,000 |
D/D |
(2,000) |
416,818 |
|
-29% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-05 |
4 |
AS |
$10.61 |
$21,220 |
D/D |
(2,000) |
418,818 |
|
-30% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-04 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
420,818 |
|
-32% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-03 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
422,818 |
|
-28% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-02 |
4 |
AS |
$10.32 |
$20,640 |
D/D |
(2,000) |
424,818 |
|
-26% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-12-01 |
4 |
AS |
$10.39 |
$20,780 |
D/D |
(2,000) |
426,818 |
|
-30% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-28 |
4 |
AS |
$10.79 |
$21,580 |
D/D |
(2,000) |
428,818 |
|
-32% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-26 |
4 |
AS |
$10.32 |
$20,640 |
D/D |
(2,000) |
430,818 |
|
-32% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-25 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
432,818 |
|
-29% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-24 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
434,818 |
|
-27% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-21 |
4 |
AS |
$10.00 |
$20,000 |
D/D |
(2,000) |
436,818 |
|
-28% |
|
| Bunn Paul A. |
Director |
– • – |
2025-11-21 |
4 |
OE |
$3.27 |
$20,438 |
D/D |
6,250 |
8,333 |
|
- |
|
| Bunn Paul A. |
Director |
– • – |
2025-11-21 |
4 |
AS |
$10.00 |
$62,500 |
D/D |
(6,250) |
2,083 |
|
-28% |
|
| Paterson Dan |
President and CEO |
• • – |
2025-11-03 |
4 |
AS |
$9.35 |
$32,146 |
D/D |
(3,299) |
438,818 |
|
-27% |
|
| Bunn Paul A. |
Director |
– • – |
2025-10-09 |
4 |
AS |
$9.06 |
$75,497 |
D/D |
(8,333) |
8,333 |
|
-22% |
|
| Calkins Daniel |
Chief Financial Officer |
• – – |
2025-09-24 |
4 |
S |
$9.23 |
$231 |
D/D |
(25) |
109,838 |
|
20% |
|
| Calkins Daniel |
Chief Financial Officer |
• – – |
2025-09-22 |
4 |
S |
$9.08 |
$518 |
D/D |
(57) |
109,863 |
|
25% |
|
| Gagnon Robert E. |
Director |
– • – |
2025-09-16 |
4 |
S |
$9.99 |
$2,807 |
D/D |
(281) |
41,961 |
|
25% |
|
220 Records found
|
|
Page 1 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.76 (11.05%) 
